Post

New research · Internal Medicine
Annals of the American Thoracic Society · 3h
Cohort studyAnnals of the American Thoracic Society · 2026

Incidence and Risk of Venous Thromboembolism in Critical Care: A Population-based Observational Cohort Study.

Alexandre Tran, Robert Talarico, Tzu-Fei Wang … Marc Carrier
Read paper
Internal MedicineCohort study

ICU exposure was associated with higher 90-day risk of venous thromboembolism.

Incidence and Risk of Venous Thromboembolism in Critical Care: A Population-based Observational Cohort Study.

Alexandre Tran … Marc Carrier
Annals of the American Thoracic Society · 2026
Background

Venous thromboembolism (venous thromboembolism) remains an important complication of critical illness, but contemporary population-level estimates of clinically recognized venous thromboembolism and ICU-associated risk are limited.

Purpose

To quantify 90-day venous thromboembolism incidence in ICU vs non-ICU hospitalizations, estimate the adjusted association between ICU exposure and venous thromboembolism, and identify factors associated with venous thromboembolism within the ICU cohort.

Methods

We conducted a population-based cohort study using linked health administrative data in Ontario, Canada (ICES).

Results

icu patients faced 38% higher risk of clot, adjusted for other factors

AHR 1.38 (95% CI 1.34 to 1.43)
null 1
1.34
1.43
CI excludes the null - significant
More results

Among 4,821,130 index hospitalizations, 575,155 (11.9%) had ICU exposure.

Ninety-day venous thromboembolism occurred in 43,913 (0.9%) overall and was higher in ICU vs non-ICU hospitalizations (1.6% vs 0.8%; Gray's test P < 0.001).

More results

In the ICU cohort, higher venous thromboembolism risk was associated with prior venous thromboembolism, cancer, recent surgery, prolonged ICU stay, extracorporeal membrane oxygenation, and traumatic brain injury.

“
Conclusion

Hospitalizations involving ICU exposure were associated with higher 90-day clinically recognized venous thromboembolism risk, and risk was concentrated in identifiable high-risk ICU subgroups, supporting risk stratification and risk-enriched future studies.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cohort Study
0.8%
an oversedation event needing naloxone reversal was rare
Randomized Trial
t = -4.35
intervention caregivers asked more questions than controls
Cohort Study
67.8%
one-year survival was far worse than the intermediate-risk group's, roughly one in three died
Review
50-100%
rheumatoid arthritis raises blood clot risk well above the general population
Cross-sectional
SIR 9.93
risk climbs sharply when relatives cluster and clotting starts young
Study
82.5%
guideline-recommended anticoagulation reached most hospitalized af patients after screening
Study
7.74
Average knowledge score rose from 5.24 to 7.74 after the education intervention
Cohort Study
34.4%
just over a third stayed safely anticoagulated, most were not